Modulation of vascular remodeling and vasoconstriction by α-phellandrene in hypoxia-induced pulmonary hypertension
Journal of Pharmacy and Pharmacology · 02.05.2026 · 78 (5)
DOI: 10.1093/jpp/rgag046 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, online erschienen am 05.05.2026. Verfasst von Zhan Ting Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medical College, Qinghai University, Xining 810001, China. Hauptthemen laut MEDLINE: Vascular Remodeling, Hypertension, Pulmonary, Vasoconstriction, Hypoxia. Die Arbeit nennt 28 Literaturangaben. Gefördert von: Natural Science Foundation of Qinghai Province, Youth Scientific Research Fund of Qinghai University.
Abstract (Originalsprache)
Objectives
This study investigated α-phellandrene (PE)’s therapeutic effects on hypoxia-induced pulmonary hypertension (HPH), with emphasis on pulmonary vasoconstriction and vascular remodeling.
Methods
A rat model of HPH was successfully established and then the hemodynamic indexes were assessed. HE and Masson’s staining were performed to observe tissue morphological changes and fibrosis. Immunohistochemistry and immunofluorescence were used to quantify Collagen I/III, and alpha-smooth muscle actin (α-SMA). malondialdehyde, glutathione, superoxide dismutase, and glutathione peroxidase assays for antioxidant status. Western blotting to analyse the protein expression levels in lung tissue of HPH rats. Key findings Our results indicate that PE significantly mitigated HPH, as evidenced by reductions in right ventricular (RV) systolic pressure, RV hypertrophy (evaluated via the RV/BW ratio and Fulton index), and key structural changes. PE effectively diminished pulmonary vascular remodeling, demonstrated by decreased vascular wall thickness and area, along with downregulation of Collagen I/III and α-SMA expression. Mechanistically, the protective effects of PE were associated with modulation of the AKT/eNOS/sGC/PKG pathway, a critical regulator of vascular tone and remodeling, as well as a reduction in oxidative stress and apoptosis.
Conclusion
These findings highlight that PE alleviates HPH through a multifaceted approach targeting vasoconstriction and vascular remodeling, underscoring its potential as a novel therapeutic agent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical College, Qinghai University, Xining 810001, China.
- Clinical Medical College & Affiliated Hospital of Chengdu University, 610106, China.
- Research Center for High Altitude Medicine, Laboratory for High Altitude Medicine of Qinghai Province, Key Laboratory for High Altitude Medicine (Ministry of Education), Key Laboratory of Application and Foundation for…
ORCID-Profile: Zhan Ting Yang
Förderung
- Natural Science Foundation of Qinghai Province
- Youth Scientific Research Fund of Qinghai University
Zitieren
APA
Yang, Z. T., Wang, Y. W., Bai, H. J., Pan, X., Lu, D. X., Li, Z. Q., Bai, G. Y., & Yang, H. (2026). Modulation of vascular remodeling and vasoconstriction by α-phellandrene in hypoxia-induced pulmonary hypertension. Journal of Pharmacy and Pharmacology, 78(5). https://doi.org/10.1093/jpp/rgag046
Vancouver
Yang ZT, Wang YW, Bai HJ, Pan X, Lu DX, Li ZQ, et al. Modulation of vascular remodeling and vasoconstriction by α-phellandrene in hypoxia-induced pulmonary hypertension. Journal of Pharmacy and Pharmacology. 2026;78(5). doi:10.1093/jpp/rgag046
BibTeX
@article{Yang2026,
author = {Yang, Zhan Ting and Wang, Yi Wen and Bai, Hai Jun and Pan, Xu and Lu, Dian Xiang and Li, Zhan Qiang and Bai, Gu Yue and Yang, Hui},
title = {Modulation of vascular remodeling and vasoconstriction by α-phellandrene in hypoxia-induced pulmonary hypertension},
journal = {Journal of Pharmacy and Pharmacology},
year = {2026},
volume = {78},
number = {5},
doi = {10.1093/jpp/rgag046}
}
EUVIMED